{"title":"通过孟德尔随机化探索阻塞性睡眠呼吸暂停和慢性肾脏疾病之间的双向因果关系。","authors":"Xiaoning Liu, Mengna Liu, Bijuan Zhong, Xinxin He, Yalai Xu, Zheng Zhou, Pei Qin","doi":"10.2147/NSS.S503387","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>It remains unclear about the causal association between obstructive sleep apnea (OSA) and chronic kidney disease (CKD) and renal function. This study aimed to explore the bidirectional causal relationship between OSA and CKD and renal function.</p><p><strong>Methods: </strong>We used a 2-sample bidirectional Mendelian randomization (MR) method to evaluate the causal relationship between OSA and estimated glomerular filtration rate from creatinine (eGFRcrea), eGFR from cystatin C (eGFRcys), urine albumin to creatinine ratio (UACR), blood urea nitrogen (BUN), and chronic kidney disease (CKD). Inverse variance weighted (IVW), MR-Egger, weighted median, MR-Egger, and pleiotropy residual sum and outlier test (MR-PRESSO) were used to calculate the β or odds ratio [OR] and their 95% CIs.</p><p><strong>Results: </strong>Genetically predicted OSA was found to be associated with BUN (β=0.040, 95% CI: 0.013-0.067, p = 0.003), but not associated with CKD (OR = 1.075, 95% CI: 0.916-1.263, p = 0.375), eGFRcrea (β=0.007, 95% CI: -0.004-0.017, p = 0.203), eGFRcys (β=-0.012, 95% CI: -0.026-0.002, p = 0.102), or UACR (β=-0.025, 95% CI: -0.058-0.007, p = 0.122). In the reverse analysis, genetically predicted eGFRcys (OR, 0.687; 95% CI, 0.497-0.950, p = 0.023) and BUN (OR, 1.686; 95% CI, 1.299-2.073, p = 0.008) was associated with an increased risk of OSA. The Cochrane's Q test reveals significant heterogeneity between various single nucleotide polymorphisms. MR-Egger indicated no evidence of genetic pleiotropy. Results were robust using other MR methods in sensitivity analyses.</p><p><strong>Conclusion: </strong>Through the two-sample MR analysis, we identified kidney function may have a causal relationship with OSA, but a causal relationship between OSA and CKD and kidney function remains uncertain. More studies are required to better understand the relationship between OSA and CKD and kidney function.</p>","PeriodicalId":18896,"journal":{"name":"Nature and Science of Sleep","volume":"17 ","pages":"1205-1215"},"PeriodicalIF":3.0000,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153958/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring Bidirectional Causality between Obstructive Sleep Apnea and Chronic Kidney Disease via Mendelian Randomization.\",\"authors\":\"Xiaoning Liu, Mengna Liu, Bijuan Zhong, Xinxin He, Yalai Xu, Zheng Zhou, Pei Qin\",\"doi\":\"10.2147/NSS.S503387\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>It remains unclear about the causal association between obstructive sleep apnea (OSA) and chronic kidney disease (CKD) and renal function. This study aimed to explore the bidirectional causal relationship between OSA and CKD and renal function.</p><p><strong>Methods: </strong>We used a 2-sample bidirectional Mendelian randomization (MR) method to evaluate the causal relationship between OSA and estimated glomerular filtration rate from creatinine (eGFRcrea), eGFR from cystatin C (eGFRcys), urine albumin to creatinine ratio (UACR), blood urea nitrogen (BUN), and chronic kidney disease (CKD). Inverse variance weighted (IVW), MR-Egger, weighted median, MR-Egger, and pleiotropy residual sum and outlier test (MR-PRESSO) were used to calculate the β or odds ratio [OR] and their 95% CIs.</p><p><strong>Results: </strong>Genetically predicted OSA was found to be associated with BUN (β=0.040, 95% CI: 0.013-0.067, p = 0.003), but not associated with CKD (OR = 1.075, 95% CI: 0.916-1.263, p = 0.375), eGFRcrea (β=0.007, 95% CI: -0.004-0.017, p = 0.203), eGFRcys (β=-0.012, 95% CI: -0.026-0.002, p = 0.102), or UACR (β=-0.025, 95% CI: -0.058-0.007, p = 0.122). In the reverse analysis, genetically predicted eGFRcys (OR, 0.687; 95% CI, 0.497-0.950, p = 0.023) and BUN (OR, 1.686; 95% CI, 1.299-2.073, p = 0.008) was associated with an increased risk of OSA. The Cochrane's Q test reveals significant heterogeneity between various single nucleotide polymorphisms. MR-Egger indicated no evidence of genetic pleiotropy. Results were robust using other MR methods in sensitivity analyses.</p><p><strong>Conclusion: </strong>Through the two-sample MR analysis, we identified kidney function may have a causal relationship with OSA, but a causal relationship between OSA and CKD and kidney function remains uncertain. More studies are required to better understand the relationship between OSA and CKD and kidney function.</p>\",\"PeriodicalId\":18896,\"journal\":{\"name\":\"Nature and Science of Sleep\",\"volume\":\"17 \",\"pages\":\"1205-1215\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-06-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153958/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature and Science of Sleep\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/NSS.S503387\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature and Science of Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NSS.S503387","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:阻塞性睡眠呼吸暂停(OSA)与慢性肾脏疾病(CKD)和肾功能之间的因果关系尚不清楚。本研究旨在探讨OSA与CKD与肾功能之间的双向因果关系。方法:采用双样本双向孟德尔随机化(MR)方法评估OSA与肾小球肌酐滤过率(eGFRcrea)、胱氨酸抑制素C (eGFRcys)、尿白蛋白/肌酐比(UACR)、血尿素氮(BUN)和慢性肾病(CKD)之间的因果关系。采用逆方差加权(IVW)、MR-Egger、加权中位数、MR-Egger和多效性残差和异常值检验(MR-PRESSO)计算β或比值比[or]及其95% ci。结果:基因预测OSA与BUN (β=0.040, 95% CI: 0.013-0.067, p = 0.003)相关,但与CKD (OR = 1.075, 95% CI: 0.916-1.263, p = 0.375)、eGFRcrea (β=0.007, 95% CI: -0.004-0.017, p = 0.203)、eGFRcys (β=-0.012, 95% CI: -0.026-0.002, p = 0.102)、UACR (β=-0.025, 95% CI: -0.058-0.007, p = 0.122)无关。在反向分析中,基因预测eGFRcys (OR, 0.687;95% CI, 0.497-0.950, p = 0.023)和BUN (OR, 1.686;95% CI, 1.299-2.073, p = 0.008)与OSA风险增加相关。Cochrane’s Q检验揭示了不同单核苷酸多态性之间的显著异质性。埃格先生没有指出遗传多效性的证据。使用其他MR方法进行敏感性分析的结果是稳健的。结论:通过两样本MR分析,我们发现肾功能可能与OSA存在因果关系,但OSA、CKD与肾功能之间的因果关系尚不确定。需要更多的研究来更好地了解OSA和CKD与肾功能之间的关系。
Exploring Bidirectional Causality between Obstructive Sleep Apnea and Chronic Kidney Disease via Mendelian Randomization.
Purpose: It remains unclear about the causal association between obstructive sleep apnea (OSA) and chronic kidney disease (CKD) and renal function. This study aimed to explore the bidirectional causal relationship between OSA and CKD and renal function.
Methods: We used a 2-sample bidirectional Mendelian randomization (MR) method to evaluate the causal relationship between OSA and estimated glomerular filtration rate from creatinine (eGFRcrea), eGFR from cystatin C (eGFRcys), urine albumin to creatinine ratio (UACR), blood urea nitrogen (BUN), and chronic kidney disease (CKD). Inverse variance weighted (IVW), MR-Egger, weighted median, MR-Egger, and pleiotropy residual sum and outlier test (MR-PRESSO) were used to calculate the β or odds ratio [OR] and their 95% CIs.
Results: Genetically predicted OSA was found to be associated with BUN (β=0.040, 95% CI: 0.013-0.067, p = 0.003), but not associated with CKD (OR = 1.075, 95% CI: 0.916-1.263, p = 0.375), eGFRcrea (β=0.007, 95% CI: -0.004-0.017, p = 0.203), eGFRcys (β=-0.012, 95% CI: -0.026-0.002, p = 0.102), or UACR (β=-0.025, 95% CI: -0.058-0.007, p = 0.122). In the reverse analysis, genetically predicted eGFRcys (OR, 0.687; 95% CI, 0.497-0.950, p = 0.023) and BUN (OR, 1.686; 95% CI, 1.299-2.073, p = 0.008) was associated with an increased risk of OSA. The Cochrane's Q test reveals significant heterogeneity between various single nucleotide polymorphisms. MR-Egger indicated no evidence of genetic pleiotropy. Results were robust using other MR methods in sensitivity analyses.
Conclusion: Through the two-sample MR analysis, we identified kidney function may have a causal relationship with OSA, but a causal relationship between OSA and CKD and kidney function remains uncertain. More studies are required to better understand the relationship between OSA and CKD and kidney function.
期刊介绍:
Nature and Science of Sleep is an international, peer-reviewed, open access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.
Specific topics covered in the journal include:
The functions of sleep in humans and other animals
Physiological and neurophysiological changes with sleep
The genetics of sleep and sleep differences
The neurotransmitters, receptors and pathways involved in controlling both sleep and wakefulness
Behavioral and pharmacological interventions aimed at improving sleep, and improving wakefulness
Sleep changes with development and with age
Sleep and reproduction (e.g., changes across the menstrual cycle, with pregnancy and menopause)
The science and nature of dreams
Sleep disorders
Impact of sleep and sleep disorders on health, daytime function and quality of life
Sleep problems secondary to clinical disorders
Interaction of society with sleep (e.g., consequences of shift work, occupational health, public health)
The microbiome and sleep
Chronotherapy
Impact of circadian rhythms on sleep, physiology, cognition and health
Mechanisms controlling circadian rhythms, centrally and peripherally
Impact of circadian rhythm disruptions (including night shift work, jet lag and social jet lag) on sleep, physiology, cognition and health
Behavioral and pharmacological interventions aimed at reducing adverse effects of circadian-related sleep disruption
Assessment of technologies and biomarkers for measuring sleep and/or circadian rhythms
Epigenetic markers of sleep or circadian disruption.